Cogent Biosciences (COGT) Shareholder's Equity Growth (3y) (2020 - 2026)
Cogent Biosciences (COGT) Shareholder's Equity Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Cogent Biosciences |
5.09 Bn |
4.22 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
39.56% |
| Dec 31, 2025 |
35.51% |
| Sep 30, 2025 |
1.42% |
| Jun 30, 2025 |
-21.41% |
| Mar 31, 2025 |
5.24% |
| Dec 31, 2024 |
6.16% |
| Sep 30, 2024 |
16.85% |
| Jun 30, 2024 |
20.60% |
| Mar 31, 2024 |
23.03% |
| Dec 31, 2023 |
3.18% |
| Sep 30, 2023 |
150.19% |
| Jun 30, 2023 |
162.60% |
| Mar 31, 2023 |
105.66% |
| Dec 31, 2022 |
100.43% |
| Sep 30, 2022 |
116.37% |
| Jun 30, 2022 |
100.28% |
| Mar 31, 2022 |
56.20% |
| Dec 31, 2021 |
52.63% |
| Sep 30, 2021 |
42.94% |
| Jun 30, 2021 |
40.53% |
